National responses for children affected by AIDS: review of progress and lessons learned
This report was commissioned by the Inter-Agency Task Team (IATT) on Children affected by HIV and AIDS' working group on National Plans of Action (NPAs).
This report was commissioned by the Inter-Agency Task Team (IATT) on Children affected by HIV and AIDS' working group on National Plans of Action (NPAs).
The global HIV and AIDS epidemic has affected sub-Saharan Africa more than any other region in the world. AIDS deaths in sub-Saharan Africa account for 72% of AIDS deaths worldwide.
This project was commissioned to establish whether agencies and services collected qualitative or quantitative data that might demonstrate links between suicidal behaviours and issues of sexuality for young people.
The report provides a summary of recent information on selected aspects of population, education and development.
This document evaluates the performance of the Eleanor Bellows Pillsbury Fund for Reproductive Health Care and Rights for Adolescent Refugees (EBP Fund).
As probably the most affected country in the world, Botswana has to develop strategic plans as well as interventions in each area of life to combat HIV/AIDS. HIV and AIDS have a significant impact on educational demand, supply and quality.
This programme is included in the Source Book of HIV/AIDS Prevention Program that presents 13 cases studies of good and promising practices of HIV/AIDS prevention programs in Sub-Saharan Africa.
This is an article informing on the launch of a World Bank publication, entitled Education and HIV/AIDS: A Sourcebook of HIV/AIDS Prevention Programme.The publication is based on studies of 13 programmes implemented in 7 countries.
The Sourcebook aims to support efforts by countries to strengthen the role of the education sector in the prevention of HIV/AIDS by sharing their practical experience of designing and implementing programs that are targeted at school-age children.
The Global Initiative on Primary Prevention of Substance Abuse (Global Initiative) is jointly executed by the United Nations International Drug Control Programme (UNDCP) and the World Health Organization (WHO). Implementation began in June 1997.